Literature DB >> 7134894

Patient and family attitudes about schizophrenia: implications for genetic counseling.

P M Schulz, S C Schulz, E Dibble, S D Targum, D P van Kammen, E S Gershon.   

Abstract

Psychiatrists are giving increased attention to genetic counseling for mental illness. However, the burden of these illnesses are perceived by families and the degree to which families feel a need for genetic counseling have yet to be established. Attitudes and perceptions measured in this study focus on etiology, familial risk, and socioeconomic burden of schizophrenia, as well as childbearing plans and the acceptability of genetic counseling. Members of 17 families, each with a child diagnosed schizophrenic, were studied using the Family Attitudes Questionnaire. The results demonstrate that the well family members view schizophrenia as a severe and debilitating illness. The results also show that there is a disparity between the attitudes of well family members and patients: 92 percent of parents compared to 25 percent of patients identified schizophrenia as a disorder associated with extreme burden. Regarding childbearing decisions, 29 percent of parents compared to 66 percent of patients say they would have children (in hindsight or in future) based on what they now know about schizophrenia in their family. This result corroborates reports from genetic counselors for other illnesses: the wish for children appears to override considerations of risk and burden for those potentially genetically affected persons who have not reached their desired family size.

Entities:  

Mesh:

Year:  1982        PMID: 7134894     DOI: 10.1093/schbul/8.3.504

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

1.  Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Rhinitis Survey Group.

Authors:  G Berdeaux; C Hervié; C Smajda; P Marquis
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

2.  Evaluating genetic counseling for family members of individuals with schizophrenia in the molecular age.

Authors:  Gregory Costain; Mary Jane Esplen; Brenda Toner; Kathleen A Hodgkinson; Anne S Bassett
Journal:  Schizophr Bull       Date:  2012-10-27       Impact factor: 9.306

3.  Evaluating genetic counseling for individuals with schizophrenia in the molecular age.

Authors:  Gregory Costain; Mary Jane Esplen; Brenda Toner; Stephen W Scherer; Wendy S Meschino; Kathleen A Hodgkinson; Anne S Bassett
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

4.  Genetic Counseling for Alcohol Addiction: Assessing Perceptions and Potential Utility in Individuals with Lived Experience and Their Family Members.

Authors:  Fayth M Kalb; Victoria Vincent; Teresa Herzog; Jehannine Austin
Journal:  J Genet Couns       Date:  2017-02-07       Impact factor: 2.537

5.  Family risk and related education and counseling needs: perceptions of adults with bipolar disorder and siblings of adults with bipolar disorder.

Authors:  H L Peay; G W Hooker; L Kassem; B B Biesecker
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

6.  Psychiatric disorders in clinical genetics I: Addressing family histories of psychiatric illness.

Authors:  Holly L Peay; Patricia McCarthy Veach; Christina G S Palmer; Beth Rosen-Sheidley; Elizabeth Gettig; Jehannine C Austin
Journal:  J Genet Couns       Date:  2007-10-26       Impact factor: 2.537

Review 7.  Ethical issues in psychiatric genetics research: points to consider.

Authors:  Barbara Bowles Biesecker; Holly Landrum Peay
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

8.  Obsessive-Compulsive Disorder: The Process of Parental Adaptation and Implications for Genetic Counseling.

Authors:  Heather Andrighetti; Alicia Semaka; S Evelyn Stewart; Cheryl Shuman; Robin Hayeems; Jehannine Austin
Journal:  J Genet Couns       Date:  2015-12-07       Impact factor: 2.537

Review 9.  Patient and family attitudes toward schizophrenia treatment.

Authors:  Farzin Irani; Mary Dankert; Steven J Siegel
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.